APA (7th ed.) Citation

Aslam, R., Burack, W. R., Segel, G. B., McVey, M., Spence, S. A., & Semple, J. W. (2018). Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid‐derived suppressor cells. British Journal of Haematology, 181(2), 262. https://doi.org/10.1111/bjh.14542

Chicago Style (17th ed.) Citation

Aslam, Rukhsana, W. Richard Burack, George B. Segel, Mark McVey, Stephen A. Spence, and John W. Semple. "Intravenous Immunoglobulin Treatment of Spleen Cells from Patients with Immune Thrombocytopenia Significantly Increases the Percentage of Myeloid‐derived Suppressor Cells." British Journal of Haematology 181, no. 2 (2018): 262. https://doi.org/10.1111/bjh.14542.

MLA (9th ed.) Citation

Aslam, Rukhsana, et al. "Intravenous Immunoglobulin Treatment of Spleen Cells from Patients with Immune Thrombocytopenia Significantly Increases the Percentage of Myeloid‐derived Suppressor Cells." British Journal of Haematology, vol. 181, no. 2, 2018, p. 262, https://doi.org/10.1111/bjh.14542.